• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织学分级不能预测接受标准治疗的犬四肢骨肉瘤的预后。

Histologic Grade Does Not Predict Outcome in Dogs with Appendicular Osteosarcoma Receiving the Standard of Care.

作者信息

Schott Courtney R, Tatiersky Laetitia J, Foster Robert A, Wood Geoffrey A

机构信息

1 Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.

出版信息

Vet Pathol. 2018 Mar;55(2):202-211. doi: 10.1177/0300985817747329. Epub 2017 Dec 28.

DOI:10.1177/0300985817747329
PMID:29284372
Abstract

Canine appendicular osteosarcoma is an aggressive bone neoplasm that imposes a short survival time. There are several published histologic grading systems for canine osteosarcoma but no universally accepted system. Location within the skeleton and therapy received are both correlated with survival time, but these factors were not always considered when the prognostic value of published grading systems was determined. Our objective was to compare 2 published histologic grading systems in a population of dogs with appendicular osteosarcoma treated with the standard of care for curative intent. Three evaluators graded 85 tumors using 2 histologic grading systems. The relationships between histologic grade as well as individual histologic features and outcome (survival time and disease-free interval) were evaluated using Kaplan-Meier survival functions and a univariate Cox proportional hazards model. Histologic grade, as assigned by any evaluator, did not correlate with outcome. Increased number of mitotic figures per 3 randomly selected 400× microscope fields, as assessed by 1 evaluator, was correlated with both survival time and disease-free interval; this was the only individual histologic feature that was significantly correlated with outcome for any evaluator. These findings cast doubt on the predictive value of routine histologic grading in dogs with appendicular osteosarcoma who receive amputation followed by adjuvant chemotherapy and highlight the need for better tools to predict outcome in canine appendicular osteosarcoma.

摘要

犬附肢骨肉瘤是一种侵袭性骨肿瘤,生存时间较短。目前已有几种已发表的犬骨肉瘤组织学分级系统,但尚无普遍接受的系统。骨骼部位和接受的治疗均与生存时间相关,但在确定已发表分级系统的预后价值时,这些因素并非总是被考虑在内。我们的目的是在一群接受根治性标准治疗的附肢骨肉瘤犬中比较两种已发表的组织学分级系统。三名评估者使用两种组织学分级系统对85个肿瘤进行了分级。使用Kaplan-Meier生存函数和单变量Cox比例风险模型评估组织学分级以及个体组织学特征与预后(生存时间和无病间期)之间的关系。任何评估者指定的组织学分级均与预后无关。一名评估者评估发现,每3个随机选择的400倍显微镜视野中,有丝分裂象数量增加与生存时间和无病间期均相关;这是任何评估者发现的唯一与预后显著相关的个体组织学特征。这些发现对接受截肢及辅助化疗的附肢骨肉瘤犬常规组织学分级的预测价值提出了质疑,并强调需要更好的工具来预测犬附肢骨肉瘤的预后。

相似文献

1
Histologic Grade Does Not Predict Outcome in Dogs with Appendicular Osteosarcoma Receiving the Standard of Care.组织学分级不能预测接受标准治疗的犬四肢骨肉瘤的预后。
Vet Pathol. 2018 Mar;55(2):202-211. doi: 10.1177/0300985817747329. Epub 2017 Dec 28.
2
Evaluation of clinical and histopathologic prognostic factors for survival in canine osteosarcoma of the extracranial flat and irregular bones.颅外扁平骨和不规则骨犬骨肉瘤生存的临床和组织病理学预后因素评估
Vet Pathol. 2013 Jul;50(4):704-8. doi: 10.1177/0300985812471542. Epub 2012 Dec 26.
3
Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs.辅助西罗莫司治疗犬附肢骨肉瘤的标准治疗:324 只犬的前瞻性随机试验结果无改善。
Clin Cancer Res. 2021 Jun 1;27(11):3005-3016. doi: 10.1158/1078-0432.CCR-21-0315. Epub 2021 Mar 22.
4
Effect of surgical site infection on survival after limb amputation in the curative-intent treatment of canine appendicular osteosarcoma: a Veterinary Society of Surgical Oncology retrospective study.手术部位感染对犬附肢骨肉瘤根治性治疗中肢体截肢术后生存的影响:一项外科肿瘤学兽医协会的回顾性研究。
Vet Surg. 2018 Nov;47(8):E88-E96. doi: 10.1111/vsu.13105. Epub 2018 Oct 10.
5
Biologic behavior and clinical outcome of 25 dogs with canine appendicular chondrosarcoma treated by amputation: a Veterinary Society of Surgical Oncology retrospective study.25只犬因患附肢软骨肉瘤接受截肢治疗后的生物学行为及临床结果:外科肿瘤学兽医协会的一项回顾性研究
Vet Surg. 2009 Dec;38(8):914-9. doi: 10.1111/j.1532-950X.2009.00606.x.
6
Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006).卡铂与阿霉素交替给药在犬肢体骨肉瘤截肢术后微小转移病例中的应用:50例(1999 - 2006年)
J Am Vet Med Assoc. 2008 May 15;232(10):1504-10. doi: 10.2460/javma.232.10.1504.
7
Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006).用辅助性卡铂治疗犬肢体骨肉瘤的预后预测因素:65例病例(1996 - 2006年)
J Am Vet Med Assoc. 2011 Jan 15;238(2):195-206. doi: 10.2460/javma.238.2.195.
8
Histologic prognosticators in feline osteosarcoma: a comparison with phenotypically similar canine osteosarcoma.猫骨肉瘤的组织学预后指标:与表型相似的犬骨肉瘤的比较。
Vet Surg. 2008 Jul;37(5):466-71. doi: 10.1111/j.1532-950X.2008.00409.x.
9
Prognosis for dogs with stage III osteosarcoma following treatment with amputation and chemotherapy with and without metastasectomy.接受截肢及化疗(有无转移灶切除术)治疗的III期骨肉瘤犬的预后
J Am Vet Med Assoc. 2017 Dec 1;251(11):1293-1305. doi: 10.2460/javma.251.11.1293.
10
Appendicular osteosarcoma in small-breed dogs: 51 cases (1986-2011).小型犬的附肢骨肉瘤:51例(1986 - 2011年)
J Am Vet Med Assoc. 2014 Jul 15;245(2):203-10. doi: 10.2460/javma.245.2.203.

引用本文的文献

1
Adjuvant Chemotherapy Is Associated With Prolonged Survival Time in Small-Breed Dogs Undergoing Amputation for Appendicular Osteosarcoma.辅助化疗与接受四肢骨肉瘤截肢术的小型犬的生存期延长有关。
Vet Comp Oncol. 2025 Jun;23(2):161-167. doi: 10.1111/vco.13041. Epub 2025 Jan 11.
2
Plasma microRNA signatures predict prognosis in canine osteosarcoma patients.血浆微小RNA特征可预测犬骨肉瘤患者的预后。
PLoS One. 2024 Dec 31;19(12):e0311104. doi: 10.1371/journal.pone.0311104. eCollection 2024.
3
Mitotic activity: A systematic literature review of the assessment methodology and prognostic value in canine tumors.
有丝分裂活性:犬肿瘤评估方法学和预后价值的系统文献回顾。
Vet Pathol. 2024 Sep;61(5):752-764. doi: 10.1177/03009858241239565. Epub 2024 Mar 27.
4
Mitotic activity: A systematic literature review of the assessment methodology and prognostic value in feline tumors.有丝分裂活性:猫科肿瘤评估方法学和预后价值的系统文献回顾。
Vet Pathol. 2024 Sep;61(5):743-751. doi: 10.1177/03009858241239566. Epub 2024 Mar 27.
5
Dog breeds and conformations predisposed to osteosarcoma in the UK: a VetCompass study.英国易患骨肉瘤的犬种及体型:一项VetCompass研究
Canine Med Genet. 2023 Jun 27;10(1):8. doi: 10.1186/s40575-023-00131-2.
6
Characterization of IGF2R Molecular Expression in Canine Osteosarcoma as Part of a Novel Comparative Oncology Approach.鉴定 IGF2R 分子在犬骨肉瘤中的表达,作为新型比较肿瘤学方法的一部分。
Int J Mol Sci. 2023 Jan 18;24(3):1867. doi: 10.3390/ijms24031867.
7
Nanocarriers in Veterinary Medicine: A Challenge for Improving Osteosarcoma Conventional Treatments.兽医学中的纳米载体:改善骨肉瘤传统治疗方法面临的一项挑战。
Nanomaterials (Basel). 2022 Dec 19;12(24):4501. doi: 10.3390/nano12244501.
8
Deep Domain Adversarial Learning for Species-Agnostic Classification of Histologic Subtypes of Osteosarcoma.基于深度领域对抗学习的骨肉瘤组织学亚型的物种不可知分类。
Am J Pathol. 2023 Jan;193(1):60-72. doi: 10.1016/j.ajpath.2022.09.009. Epub 2022 Oct 27.
9
Prognostic significance of the urokinase plasminogen activator system in tissue and serum of dogs with appendicular osteosarcoma.尿激酶纤溶酶原激活系统在犬附肢骨肉瘤组织和血清中的预后意义。
PLoS One. 2022 Sep 29;17(9):e0273811. doi: 10.1371/journal.pone.0273811. eCollection 2022.
10
Canine Idiopathic Arteriopathy, Appendicular Bone Infarcts, and Neoplastic Transformation of Bone Infarcts in 108 Dogs ().犬特发性动脉病、附肢骨梗死和骨梗死的肿瘤性转化在 108 只狗中()。
Comp Med. 2022 Oct 1;72(5):306-319. doi: 10.30802/AALAS-CM-22-000037. Epub 2022 Sep 16.